Page 1 of Clinical Trials for Refractory Multiple Myeloma, 709 Total Matches
- 1RecruitingLast Updated: April 16, 2012Condition(s): Multiple Myeloma
- 2Active, not recruitingLast Updated: November 23, 2011Condition(s): Relapsed and Bortezomib Refractory Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma
- 3CompletedLast Updated: August 3, 2009Condition(s): Relapse; Refractory Multiple Myeloma
- 4Not yet recruitingLast Updated: March 27, 2012Condition(s): Relapsed Multiple Myeloma; Refractory Multiple Myeloma
- 5RecruitingLast Updated: April 27, 2012Condition(s): Relapsed and Refractory Multiple Myeloma
- 6RecruitingLast Updated: April 27, 2012Condition(s): Relapsed and Refractory Multiple Myeloma
- 7TerminatedLast Updated: January 6, 2011Condition(s): Multiple Myeloma
- 8Active, not recruitingLast Updated: March 4, 2011Condition(s): Multiple Myeloma
- 9CompletedLast Updated: June 16, 2011Condition(s): Multiple Myeloma
- 10CompletedLast Updated: February 15, 2011Condition(s): Refractory Multiple Myeloma
- 11Active, not recruitingLast Updated: June 14, 2010Condition(s): Multiple Myeloma; Relapsed Multiple Myeloma; Refractory Multiple Myeloma
- 12RecruitingLast Updated: April 11, 2012Condition(s): Multiple Myeloma
- 13CompletedLast Updated: April 17, 2012Condition(s): Relapsed or Refractory Multiple Myeloma
- 14Active, not recruitingLast Updated: June 9, 2011Condition(s): Relapsed and/or Refractory Multiple Myeloma
- 15Active, not recruitingLast Updated: April 29, 2009Condition(s): Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
- 16RecruitingLast Updated: March 23, 2012Condition(s): Refractory Multiple Myeloma
- 17RecruitingLast Updated: April 4, 2012Condition(s): Multiple Myeloma; Multiple Myeloma in Relapse; Refractory Multiple Myeloma
- 18RecruitingLast Updated: May 14, 2012Condition(s): Refractory Multiple Myeloma
- 19CompletedLast Updated: September 22, 2011Condition(s): Relapsed Or Refractory Multiple Myeloma
- 20RecruitingLast Updated: February 1, 2012Condition(s): Refractory Multiple Myeloma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Refractory+Multiple+Myeloma
